Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBAT-Myopia: Atropine vs Atropine + Bifocals for Progressive Myopia
NCT07614113Completed
- Sponsor
- The University of Faisalabad
- Start
- Feb 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of NVK002 in myopia (2 arms), sponsored by The University of Faisalabad. Primary endpoint: Spherical Equivalent Refraction at 12 months. Started Feb 2025; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07614113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07614113.